TensorFlow is an open source machine learning framework developed by Google, designed to build and train AI models for a wide ...

The highlight of the launch is the Gemini 2.0 Pro Experimental model. This model is a real powerhouse, boasting an impressive ...

To gain competitive advantage from gen AI, enterprises need to be able to add their own expertise to off-the-shelf systems. Yet standard enterprise data stores aren't a good fit to train large ...

“Commercial negotiations between NHS England and Vertex remain on-track and ... Identification Rule tool – This is a software tool which enables the identification of specialised services activity ...

With its latest update, Regula Document Reader SDK, a comprehensive software solution for identity document verification, ensures 100% support for the new ISO/IEC 39794-5 standard regulating the ...

Despite healthcare sector struggles, Vertex Pharmaceuticals has outperformed both its biotech peers and the broader market since 2022. The company dominates the cystic fibrosis market and is ...

Vertex Pharmaceuticals recently obtained approval for its non-opioid pain medication. The drug could become a blockbuster and a key part of Vertex's portfolio. The stock has been rising in value ...

Gemini 2.0 Flash is now available through Google’s API Developers can access Gemini 2.0 Flash in the Google AI Studio and Vertex AI ... Gemini 2.0 cooking: the standard Flash variant, Gemini ...

The Parnassus Growth Equity Fund returned 4.85% (net) for Q4 2024, underperforming the Russell 1000 Growth Index’s 7.07%.

Here's why they think Eli Lilly (NYSE: LLY), Summit Therapeutics (NASDAQ: SMMT), and Vertex Pharmaceuticals (NASDAQ: VRTX) could trounce the market in 2025. David Jagielski (Eli Lilly): For years ...

Google Cloud's revenue grew 30% YoY in Q4'24 with margins up to 17.51%, driven by AI advancements. Discover their $75B ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...